QRISK validation and evaluation Authors' reply

QRISK validation and evaluation Authors' reply

書誌詳細
主要な著者:	Collins, G, Altman, D
フォーマット:	Journal article
言語:	English
出版事項:	2009

類似資料

UPDATED VERSION OF QRISK2 Authors' reply to Bird
著者:: Collins, G, 等
出版事項: (2012)

QRISK validation and evaluation. QRISK may be less useful.
著者:: Liew, S, 等
出版事項: (2009)

QRISK validation and evaluation: QRISK may be less useful
著者:: Su, M, 等
出版事項: (2009)

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.
著者:: Collins, G, 等
出版事項: (2009)

An independent external validation and evaluation of QRISK cardiovascular risk prediction: A prospective open cohort study
著者:: Collins, G, 等
出版事項: (2009)

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study
著者:: Collins, G, 等
出版事項: (2009)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.
著者:: Collins, G, 等
出版事項: (2010)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study
著者:: Collins, G, 等
出版事項: (2010)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.
著者:: Collins, G, 等
出版事項: (2010)

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
著者:: Collins, G, 等
出版事項: (2012)

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
著者:: Collins, G, 等
出版事項: (2012)

QRISK2-2011 predicted cardiovascular disease in adult general practice patients
著者:: Collins, G, 等
出版事項: (2012)

Authors' reply to Bird.
著者:: Collins, G, 等
出版事項: (2012)

Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
著者:: Manpreet Singh, 等
出版事項: (2022-07-01)

The authors reply
著者:: Collins, R, 等
出版事項: (2009)

Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank
著者:: Parsons, RE, 等
出版事項: (2023)

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
著者:: Hippisley-Cox, J, 等
出版事項: (2017)

Authors' reply [5]
著者:: Chen, Z, 等
出版事項: (2006)

Assessment of QRISK3 Score in Normoglycaemic, Prediabetic and Diabetic Subjects: An Observational Study
著者:: Aayushee Rao, 等
出版事項: (2023-07-01)

Authors' reply:
著者:: Garety, P, 等
出版事項: (2008)

Fetal growth and ethnic variation--authors' reply.
著者:: Villar, J, 等
出版事項: (2014)

Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus.
著者:: Mónica Vázquez-Del Mercado, 等
出版事項: (2018-01-01)

Author Reply
著者:: Krishna G Seshadri
出版事項: (2014-01-01)

Statins and diabetes - Authors' reply
著者:: Kearney, P, 等
出版事項: (2008)

Author′s Reply
著者:: Farid E Stephan, 等
出版事項: (2016-01-01)

Author's reply
著者:: Freeman, D
出版事項: (2008)

Safety and efficacy of statins - Authors' reply
著者:: Collins, R, 等
出版事項: (2017)

Reply to author
著者:: Thao, L, 等
出版事項: (2018)

Authors' Reply
著者:: Madhai L Teegala, 等
出版事項: (2018-07-01)

The effect of long-acting injectable antipsychotics on QRISK3 in patients with bipolar disorder and schizophrenia
著者:: V. Erbasan, 等
出版事項: (2023-03-01)

Authors′ reply
著者:: Vinita G Rao, 等
出版事項: (2012-01-01)

Authors' reply.
著者:: Garety, P, 等
出版事項: (2014)

Authors' Reply
著者:: P McKenna, 等
出版事項: (2008-04-01)

Reply of the Authors
著者:: Jessica K. Wu, B.S, 等
出版事項: (2022-12-01)

Authors′ Reply
著者:: Ramesh Kekunnaya, 等
出版事項: (2014-01-01)

The Authors' reply.
著者:: Lasserson, D, 等
出版事項: (2011)

The authors reply
著者:: David Vlahov, 等

Author's Reply
著者:: Georgios D Panos, 等
出版事項: (2018-01-01)

Authors' Reply
著者:: SV Vaidya, 等
出版事項: (2004-06-01)

Authors' reply
著者:: Leucht, S, 等
出版事項: (2013)